Filters

See more specimen types...

Other countries

Results: 1 to 18 of 18

Tests names and labsConditionsGenes and analytesMethods

Pleuropulmonary blastoma

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CustomNext-Cancer

Ambry Genetics
United States
6867
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Cancer Sequencing and Deletion/Duplication Panel

PreventionGenetics
United States
4335
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

DICER1 Syndrome via the DICER1 Gene

PreventionGenetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Pleuropulmonary Blastoma (PPB) Family Tumor and Dysplasia Syndrome, DICER1 Syndrome

Ambry Genetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Pediatric Solid Tumors Panel

Invitae
United States
9148
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Renal / Urinary Cancer Comprehensive Panel

Fulgent Genetics
United States
77327
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Sarcoma Comprehensive Panel

Fulgent Genetics
United States
92026
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Cancer Panel

Fulgent Genetics
United States
1735124
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Nervous System / Brain Cancer Comprehensive Panel

Fulgent Genetics
United States
83725
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Thyroid Cancer Comprehensive Panel

Fulgent Genetics
United States
4657
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Sarcoma Panel

Invitae
United States
2726
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Multi-Cancer Panel

Invitae
United States
14180
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae DICER1 Syndrome Test

Invitae
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Common Hereditary Cancers Panel (Breast, Gyn, GI)

Invitae
United States
7642
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Cancer Predisposition

Asper Biogene Asper Biogene LLC
Estonia
12789
  • C Sequence analysis of the entire coding region

DICER1

Fulgent Genetics
United States
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Cancer NGS Panel

Fulgent Genetics
United States
256112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 18 of 18

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center